EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Soluble ST2 as a Useful Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients

Mikyoung Park iD, Mina Hur iD, Hanah Kim iD, Chae Hoon Lee, Jong Ho Lee iD, Hyung Woo Kim, Minjeong Nam iD, Seungho Lee

Diagnostics · 10.01.2023 · 13 (2) · 259

DOI: 10.3390/diagnostics13020259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 10.01.2023. Verfasst von Mikyoung Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Republic of Kor…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Soluble suppression of tumorigenesis-2 (sST2) is an emerging biomarker for sepsis as well as for heart failure. We investigated the prognostic utility of sST2 for predicting clinical outcomes in hospitalized coronavirus disease 2019 (COVID-19) patients. In a total of 52 hospitalized COVID-19 patients, sST2 levels were measured using the ichroma ST2 assay (Boditech Med Inc., Chuncheon-si, Gang-won-do, Republic of Korea). Clinical outcomes included intensive care unit (ICU) admission, ventilator use, extracorporeal membrane oxygenation (ECMO) use, and 30-day mortality. sST2 was analyzed according to clinical outcomes. sST2, sequential organ failure assessment (SOFA) score, critical disease, and 4C mortality score were compared using the receiver operating characteristic (ROC) curve and Kaplan–Meier methods for clinical outcomes. The sST2 level differed significantly according to ICU admission, ventilator use, ECMO use, and 30-day mortality (all p < 0.05). On ROC curve analysis, sST2 predicted ICU admission, ventilator use, ECMO use, and 30-day mortality comparable to SOFA score but significantly better than critical disease. sST2 predicted ICU admission, ventilator use, and ECMO use significantly better than the 4C mortality score. On Kaplan–Meier survival analysis, hazard ratios (95% confidence interval) were 8.4 (2.7–26.8) for sST2, 14.8 (3.0–71.7) for SOFA score, 1.8 (0.5–6.5) for critical disease, and 11.7 (3.4–40.1) for 4C mortality score. This study demonstrated that sST2 could be a useful biomarker to predict ICU admission, ventilator use, ECMO use, and 30-day mortality in hospitalized COVID-19 patients. sST2 may be implemented as a prognostic COVID-19 biomarker in clinical practice.

Schlagwörter

Stichwörter der Autor:innen

COVID-19biomarkerclinical outcomepredictionsoluble ST2

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Republic of Korea.
  • Department of Laboratory Medicine, Konkuk University School of Medicine, Seoul 05030, Republic of Korea.
  • Department of Laboratory Medicine, Yeungnam University College of Medicine, Daegu 42415, Republic of Korea.
  • Department of Laboratory Medicine, Korea University Anam Hospital, Seoul 02841, Republic of Korea.
  • Department of Preventive Medicine, College of Medicine, Dong-A University, Busan 49201, Republic of Korea.

ORCID-Profile: Mikyoung Park, Mina Hur, Hanah Kim, Jong Ho Lee, Minjeong Nam

Zitieren

APA

Park, M., Hur, M., Kim, H., Lee, C. H., Lee, J. H., Kim, H. W., Nam, M., & Lee, S. (2023). Soluble ST2 as a Useful Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients. Diagnostics, 13(2), 259. https://doi.org/10.3390/diagnostics13020259

Vancouver

Park M, Hur M, Kim H, Lee CH, Lee JH, Kim HW, et al. Soluble ST2 as a Useful Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients. Diagnostics. 2023;13(2):259. doi:10.3390/diagnostics13020259

BibTeX
@article{Park2023,
  author = {Park, Mikyoung and Hur, Mina and Kim, Hanah and Lee, Chae Hoon and Lee, Jong Ho and Kim, Hyung Woo and Nam, Minjeong and Lee, Seungho},
  title = {Soluble ST2 as a Useful Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients},
  journal = {Diagnostics},
  year = {2023},
  volume = {13},
  number = {2},
  pages = {259},
  doi = {10.3390/diagnostics13020259}
}
Kostenlos starten →